Non-nucleoside reverse transcriptase inhibitors.
Bowers
M
M
D000081:Acetamides / Q000627:therapeutic use; D000098:Acetophenones / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D020008:Delavirdine; D017277:Drug Approval; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006678:HIV / Q000187:drug effects; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D019829:Nevirapine; D010879:Piperazines / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000081:Acetamides; D000098:Acetophenones; D000998:Antiviral Agents; D007211:Indoles; D010879:Piperazines; D011725:Pyridines; D018894:Reverse Transcriptase Inhibitors; C080073:loviride; D019829:Nevirapine; D020008:Delavirdine